{"transactions":[{"id":757173,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2026-06-01T11:33:22.000Z","date":"2026-05-29","kind":"other","planned":false,"acquired":false,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The American Depositary Shares reported in this row consist of RSUs that were granted to the Reporting Person by the Issuer on July 1, 2025 vest and become exercisable according to following schedule: 25% on April 10, 2026, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on April 10, 2029."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."}],"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001178913-26-003004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891326003004/ownership.xml","form_type":"4"}},{"id":757172,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2026-06-01T11:33:22.000Z","date":"2026-05-29","kind":"other","planned":false,"acquired":false,"shares":31712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The American Depositary Shares reported in this row consist of restricted share units (\"RSUs\") that were granted to the Reporting Person by the Issuer on November 18, 2024, and vest and become exercisable according to following schedule: 25% on October 1, 2025, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on October 1, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."}],"balance_after":31712,"source":{"system":"sec-edgar","filing":"0001178913-26-003004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891326003004/ownership.xml","form_type":"4"}},{"id":757171,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2026-06-01T11:33:22.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":false,"shares":4926,"price":2.08,"value":10246.08,"ownership":{"direct":true},"balance_after":139131,"source":{"system":"sec-edgar","filing":"0001178913-26-003004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891326003004/ownership.xml","form_type":"4"}},{"id":757170,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2026-06-01T11:33:22.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":false,"shares":4878,"price":2.05,"value":9999.9,"ownership":{"direct":true},"balance_after":134205,"source":{"system":"sec-edgar","filing":"0001178913-26-003004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891326003004/ownership.xml","form_type":"4"}},{"id":2063033,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-01-05T21:01:17.000Z","date":"2016-10-28","kind":"grant","acquired":true,"shares":33725,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kobi George, the Reporting Person's spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":33725,"derivative":{"exercise_price":0.8,"expiration_date":"2026-10-27","underlying":"American Depositary Shares","underlying_shares":33725},"source":{"system":"sec-edgar","filing":"0001178913-23-000076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891323000076/ownership.xml","form_type":"4"}},{"id":2063032,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-01-05T21:01:17.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":131698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options have vested and are exercisable as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":131698,"derivative":{"exercise_price":1.49,"expiration_date":"2028-03-15","underlying":"American Depositary Shares","underlying_shares":131698},"source":{"system":"sec-edgar","filing":"0001178913-23-000076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891323000076/ownership.xml","form_type":"4"}},{"id":2063031,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"American Depositary Shares","published_at":"2023-01-05T21:01:17.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":6100,"price":5.0268,"value":30663.48,"ownership":{"direct":false,"nature":"By Kobi George, the Reporting Person's spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022."}],"balance_after":251147,"source":{"system":"sec-edgar","filing":"0001178913-23-000076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891323000076/ownership.xml","form_type":"4"}},{"id":2063030,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"American Depositary Shares","published_at":"2023-01-05T21:01:17.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":7700,"price":5.0268,"value":38706.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022."}],"balance_after":317075,"source":{"system":"sec-edgar","filing":"0001178913-23-000076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891323000076/ownership.xml","form_type":"4"}},{"id":2112420,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-11-17T21:56:23.000Z","date":"2016-10-28","kind":"grant","acquired":true,"shares":33725,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kobi George, the Reporting Person's spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":33725,"derivative":{"exercise_price":0.8,"expiration_date":"2026-10-27","underlying":"American Depositary Shares","underlying_shares":33725},"source":{"system":"sec-edgar","filing":"0001178913-22-004098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891322004098/ownership.xml","form_type":"4"}},{"id":2112419,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-11-17T21:56:23.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":131698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options have vested and are exercisable as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":131698,"derivative":{"exercise_price":1.49,"expiration_date":"2028-03-15","underlying":"American Depositary Shares","underlying_shares":131698},"source":{"system":"sec-edgar","filing":"0001178913-22-004098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891322004098/ownership.xml","form_type":"4"}},{"id":2112418,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"American Depositary Shares","published_at":"2022-11-17T21:56:23.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":257248,"price":2.0848,"value":536310.6304,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price pursuant to the share purchase agreement between Adi Mor, Kobi George, and the Issuer, as disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 16, 2022."}],"balance_after":257247,"source":{"system":"sec-edgar","filing":"0001178913-22-004098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891322004098/ownership.xml","form_type":"4"}},{"id":2112417,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":42807,"kind":"person","name":"Mor George Adi","position":1,"cik":"0001851069","reported_name":"Mor George Adi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"American Depositary Shares","published_at":"2022-11-17T21:56:23.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":324775,"price":2.0848,"value":677090.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price pursuant to the share purchase agreement between Adi Mor, Kobi George, and the Issuer, as disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 16, 2022."}],"balance_after":324775,"source":{"system":"sec-edgar","filing":"0001178913-22-004098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851069/000117891322004098/ownership.xml","form_type":"4"}}]}